These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer. Falcone F, Sabbatani S, Fini A, Turba E, Magri P, D'Ales A. Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127 [Abstract] [Full Text] [Related]
3. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA, Marín J, Jover JM, Fernández R, Fradejas J, Moreno M. Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [Abstract] [Full Text] [Related]
4. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H. J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167 [Abstract] [Full Text] [Related]
5. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas. Cangemi V, Volpino P, Fiori E, Giammarco A, Piat G. J Nucl Med Allied Sci; 1987 Feb; 31(2):189-93. PubMed ID: 3476692 [No Abstract] [Full Text] [Related]
6. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers]. Capocasale E, Contini S, Rossetti A, Del Sante G, Gregori G. Acta Biomed Ateneo Parmense; 1985 Feb; 56(6):231-6. PubMed ID: 2940782 [Abstract] [Full Text] [Related]
7. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma. Satake K, Kanazawa G, Kho I, Chung YS, Umeyama K. J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396 [Abstract] [Full Text] [Related]
8. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Fucini C, Tommasi SM, Rosi S, Malatantis G, Cardona G, Panichi S, Bettini U. Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172 [Abstract] [Full Text] [Related]
9. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G, Domschke S, Krapf F, Schneider MU, Iro H, Domschke W. Dtsch Med Wochenschr; 1984 Aug 31; 109(35):1309-12. PubMed ID: 6590287 [Abstract] [Full Text] [Related]
10. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y, Ogawa K, Matsumoto N, Hosokawa T, Kikuchi T, Koyama N, Haga S, Kajiwara T, Sakakibara N. Gan No Rinsho; 1987 Aug 31; 33(10):1274-80. PubMed ID: 2444727 [Abstract] [Full Text] [Related]
11. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Buccheri GF, Ferrigno D, Sartoris AM, Violante B, Vola F, Curcio A. Cancer; 1987 Jul 01; 60(1):42-50. PubMed ID: 3472637 [Abstract] [Full Text] [Related]
13. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis. Ståhle E, Glimelius B, Bergström R, Påhlman L. Eur J Surg Oncol; 1988 Aug 01; 14(4):287-96. PubMed ID: 3165870 [Abstract] [Full Text] [Related]
15. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. Rasmuson T, Björk GR, Damber L, Holm SE, Jacobsson L, Jeppsson A, Stigbrand T, Westman G. Acta Radiol Oncol; 1984 Aug 01; 23(1):27-32. PubMed ID: 6328884 [Abstract] [Full Text] [Related]
16. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A. Nuklearmedizin; 1986 Feb 01; 25(1):9-14. PubMed ID: 3459133 [Abstract] [Full Text] [Related]